{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:10:13Z","timestamp":1786684213433,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jns.2018.01.016","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T21:46:16Z","timestamp":1517348776000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Neuromuscular diseases associated with Human Immunodeficiency Virus infection"],"prefix":"10.1016","volume":"387","author":[{"given":"Devin E.","family":"Prior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2018.01.016_bb0005","series-title":"Handbook of Clinical Neurology Neurologic Aspects of Systemic Disease Part III","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/B978-0-7020-4088-7.00090-0","article-title":"Neurologic diseases in HIV-infected patients","author":"Bilgrami","year":"2014"},{"key":"10.1016\/j.jns.2018.01.016_bb0010","first-page":"1557","article-title":"Neurologic complications of human immunodeficiency virus infection","volume":"21","author":"Nath","year":"2015","journal-title":"Continuum (Minneap., Minn.)"},{"key":"10.1016\/j.jns.2018.01.016_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1474-4422(13)70002-4","article-title":"Manifestations of HIV infection in the peripheral nervous system","volume":"12","author":"Centner","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2018.01.016_bb0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/COH.0000000000000103","article-title":"HIV neuropathy","volume":"9","author":"Kaku","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jns.2018.01.016_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11904-014-0211-2","article-title":"Understanding the etiology and management of HIV-associated peripheral neuropathy","volume":"11","author":"Stavros","year":"2014","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.jns.2018.01.016_bb0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.j.pain.0000461252.75089.bf","article-title":"Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy","volume":"156","author":"Malvar","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jns.2018.01.016_bb0035","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.5588\/ijtld.15.0467","article-title":"Isoniazid exposure and pyridoxine levels in human immunodeficiency virus associated distal sensory neuropathy","volume":"19","author":"Van Der Watt","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.jns.2018.01.016_bb0040","first-page":"331","article-title":"Neuromuscular complications in HIV: effects of aging","volume":"18","author":"Robinson-Papp","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2018.01.016_bb0045","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mus.21465","article-title":"Neuromuscular diseases associated with HIV-1 infection","volume":"40","author":"Robinson-Papp","year":"2009","journal-title":"Muscle Nerve"},{"issue":"1002","key":"10.1016\/j.jns.2018.01.016_bb0050","article-title":"Evolution of sensory neuropathy after initiation of antiretroviral therapy","volume":"10","author":"Centner","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2018.01.016_bb0055","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1097\/QAD.0b013e32833ef5d7","article-title":"The ESR in HIV: a neglected parameter?","volume":"24","author":"Lowe","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jns.2018.01.016_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01646922","article-title":"Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients","volume":"16","author":"Hagberg","year":"1988","journal-title":"Infection"},{"key":"10.1016\/j.jns.2018.01.016_bb0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcp\/aqv088","article-title":"Oligoclonal bands of immunoglobulins in serum leading to diagnosis of human immunodeficiency virus 1 infection","volume":"145","author":"Soong","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"issue":"164","key":"10.1016\/j.jns.2018.01.016_bb0070","article-title":"Infectious diseases causing autonomic dysfunction","volume":"27","author":"Atral","year":"2017","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.jns.2018.01.016_bb0075","first-page":"172","article-title":"Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy","volume":"19","author":"Robinson-Papp","year":"2013","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2018.01.016_bb0080","first-page":"2502","article-title":"Quantitative autonomic testing","volume":"53","author":"Novak","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jns.2018.01.016_bb0085","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating Polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria","volume":"46","author":"Barohn","year":"1989","journal-title":"Arch. Neurol."},{"issue":"315","key":"10.1016\/j.jns.2018.01.016_bb0090","article-title":"A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients","volume":"4","author":"Moodley","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2018.01.016_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410210107","article-title":"Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection","volume":"21","author":"Cornblath","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2018.01.016_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2015.11.013","article-title":"CIDP in a HIV endemic population: a prospective case series from Johannesburg, South Africa","volume":"363","author":"Mochan","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2018.01.016_bb0105","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00002030-200405210-00002","article-title":"HIV-associated nephropathy","volume":"18","author":"Ross","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jns.2018.01.016_bb0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2018.01.016_bb0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5692\/clinicalneurol.53.362","article-title":"Successful treatment of HIV-associated chronic inflammatory demyelinating polyneuropathy by early initiation of highly active anti-retroviral therapy","volume":"53","author":"Kume","year":"2013","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jns.2018.01.016_bb0120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/mus.10484","article-title":"The peripheral nerve complications of human immunodeficiency virus (HIV) infection","volume":"28","author":"Brew","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2018.01.016_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4065\/81.2.213","article-title":"Human immunodeficiency virus-associated peripheral neuropathies","volume":"81","author":"Ferrari","year":"2006","journal-title":"Mayo Clin. Proc."},{"issue":"71","key":"10.1016\/j.jns.2018.01.016_bb0130","article-title":"Plasma cytokine profiles in HIV-1 infected patients developing neuropathic symptoms shortly after commencing antiretroviral therapy: a case-control study","volume":"14","author":"Van Der Watt","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jns.2018.01.016_bb0135","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.21484","article-title":"Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy","volume":"64","author":"Ellis","year":"2008","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2018.01.016_bb0140","first-page":"2159","article-title":"Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study","volume":"4","author":"Dal Pan","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.01.016_bb0145","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM198504043121402","article-title":"Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome","volume":"312","author":"Petito","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.01.016_bb0150","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000140469.18782.05","article-title":"Treatment of AIDS-associated myelopathy with L-methionine: a placebo-controlled study","volume":"63","author":"Di Rocco","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.01.016_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/apc.2008.0018","article-title":"Pilot study of intravenous immunoglobulin in HIV-associated myelopathy","volume":"23","author":"Cikurel","year":"2009","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.jns.2018.01.016_bb0160","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00002281-199511000-00006","article-title":"Myopathy and HIV infection","volume":"7","author":"Chariot","year":"1995","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2018.01.016_bb0165","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/brain\/119.4.1357","article-title":"The effect of zidovudine on skeletal muscles mtDNA in HIV-1 infected patients with mild or no muscle dysfunction","volume":"119","author":"Casademont","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.jns.2018.01.016_bb0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mus.20338","article-title":"Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART)","volume":"32","author":"Authier","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2018.01.016_bb0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jnen\/nlv023","article-title":"T cell mediated inflammatory myopathies in HIV-positive individuals: a histological study of 19 cases","volume":"75","author":"Hiniker","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2018.01.016_bb0180","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1089\/aid.2014.0113","article-title":"Skeletal muscle toxicity in HIV-1-infected patients treated with a Raltegravir-containing antiretroviral therapy: a cohort study","volume":"30","author":"Calza","year":"2014","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jns.2018.01.016_bb0185","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.nmd.2017.05.008","article-title":"Clinical, histological and radiological responses to methylprednisolone in HIV-associated rod myopathy","volume":"27","author":"Silva","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2018.01.016_bb0190","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1001\/archinte.1988.00380070100023","article-title":"Pyomyositis in a patient with acquired immunodeficiency syndrome","volume":"148","author":"Gaut","year":"1988","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jns.2018.01.016_bb0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaut.2015.01.010","article-title":"The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review","volume":"59","author":"Ghrenassia","year":"2015","journal-title":"J. Autoimmun."},{"issue":"suppl","key":"10.1016\/j.jns.2018.01.016_bb0200","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1086\/367561","article-title":"Weight loss and wasting in patients infected with human immunodeficiency virus","volume":"36","author":"Grinspoon","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jns.2018.01.016_bb0205","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00415-015-7639-1","article-title":"MuSK myasthenia gravis as a manifestation of immune restoration disease in an HIV-positive patient","volume":"262","author":"Ragunathan","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2018.01.016_bb0210","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.clineuro.2011.03.019","article-title":"HIV-associated myasthenia gravis and impact of HAART: one case report and a brief review","volume":"113","author":"Hung","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2018.01.016_bb0215","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.nmd.2010.06.007","article-title":"Polymyositis in African HIV-infected subjects","volume":"20","author":"Heckmann","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2018.01.016_bb0220","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.0000000000003821","article-title":"Overlapping features of polymyositis and inclusion body myositis in HIV infected patients","volume":"88","author":"Lloyd","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.01.016_bb0225","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/WNL.0000000000003258","article-title":"HIV-associated motor neuron disease","volume":"87","author":"Bowen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.01.016_bb0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.hivar.2015.02.004","article-title":"A rare presentation of reversible ALS in HIV infection","volume":"14","author":"John","year":"2015","journal-title":"HIV AIDS Rev."},{"key":"10.1016\/j.jns.2018.01.016_bb0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2321-9157.135746","article-title":"Amyotrophic lateral sclerosis as sole neurological manifestation of human immunodeficiency virus","volume":"2","author":"Subrata","year":"2014","journal-title":"J. HIV Human Reprod."},{"issue":"113","key":"10.1016\/j.jns.2018.01.016_bb0240","article-title":"Acute lower motor neuron syndrome and spinal cord gray matter hyperintensities in HIV infection","volume":"2","author":"Bogoch","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2018.01.016_bb0245","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/aid.2006.22.979","article-title":"Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals","volume":"22","author":"Contreras-Galindo","year":"2006","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jns.2018.01.016_bb0250","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/aid.2006.0117","article-title":"HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro","volume":"23","author":"Contreras-Galindo","year":"2007","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"307","key":"10.1016\/j.jns.2018.01.016_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac8201","article-title":"Human endogenous retrovirus-K contributes to motor neuron disease","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jns.2018.01.016_bb0260","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1097\/00002030-200012010-00010","article-title":"Immunolocalization of HIV envelope Gp120 in HIV encephalitis with dementia","volume":"14","author":"Jones","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jns.2018.01.016_bb0265","first-page":"1319","article-title":"Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy","volume":"18","author":"Kranick","year":"2012","journal-title":"Continuum (Minneap., Minn.)"},{"key":"10.1016\/j.jns.2018.01.016_bb0270","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ncl.2008.04.001","article-title":"Diagnosis and management of HIV-associated neuropathy","volume":"26","author":"Gonzalez-Duarte","year":"2008","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jns.2018.01.016_bb0275","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa030264","article-title":"Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection","volume":"349","author":"Robbins","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.01.016_bb0280","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/01.aids.0000131309.70451.fe","article-title":"HIV-associated neuromuscular weakness syndrome","volume":"18","author":"Simpson","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jns.2018.01.016_bb0285","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAI.0b013e3182832578","article-title":"Skeletal muscle toxicity associated with Raltegravir-based combination antiretroviral therapy in HIV-infected adults","volume":"62","author":"Lee","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jns.2018.01.016_bb0290","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijantimicag.2014.10.013","article-title":"Muscle symptoms and creatine phosphokinase elevations in patients receiving Raltegravir in clinical practice: results from the SCOLTA project long-term surveillance","volume":"45","author":"Madeddu","year":"2015","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18300248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18300248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T20:36:34Z","timestamp":1570653394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18300248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":58,"alternative-id":["S0022510X18300248"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.01.016","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromuscular diseases associated with Human Immunodeficiency Virus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}